Literature DB >> 26465123

Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.

Emilie J Gladstone1, Kate Smolina, Deirdre Weymann, Kimberly Rutherford, Steven G Morgan.   

Abstract

OBJECTIVES: We quantify patterns in prescription opioid dispensations to individuals who suffered a prescription opioid-related death. In addition, we examine the relationship between opioid dispensations and prescription opioid-related deaths in geographic regions of British Columbia (BC).
METHODS: We used population-based administrative data on prescription drug dispensations to identify patterns in prescription opioid dispensations to individuals who suffered a prescription opioid-related death. We also computed the quantity of prescription opioids dispensed (morphine equivalents) in small geographic regions in BC from 2004 to 2013. We identified prescription opioid-related deaths in these small geographic areas using mortality data from BC Vital Statistics and investigated the relationship between rates of prescription opioid dispensing and rates of prescription opioid death in small geographic areas in BC by sex. We examined differences in our results when limiting opioid dispensations to strong opioids and weak opioids.
RESULTS: Many individuals who suffered a prescription opioid-related death did not have an active opioid prescription in the 60 days before death (46% of women and 71% of men). Rates of prescription opioid dispensing and opioid-related deaths vary substantially across geographic regions in BC. The area-level relationship between rate of prescription opioid dispensing and rate of unintentional prescription opioid-related death is positive and statistically significant for both men and women (P<0.001). This relationship holds when opioid prescribing is limited to strong opioids.
CONCLUSION: Targeted efforts to reduce high levels of opioid prescribing in BC, particularly dispensations of strong opioids and codeine, may substantially reduce opioid-related harms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26465123     DOI: 10.1097/MLR.0000000000000431

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  8 in total

1.  Medical Use and Misuse of Prescription Opioids in the US Adult Population: 2016-2017.

Authors:  Pamela C Griesler; Mei-Chen Hu; Melanie M Wall; Denise B Kandel
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

Review 2.  The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight.

Authors:  Joseph K Eibl; Kristen Morin; Esa Leinonen; David C Marsh
Journal:  Can J Psychiatry       Date:  2017-05-19       Impact factor: 4.356

Review 3.  Sex differences in prescription opioid use.

Authors:  Mirsada Serdarevic; Catherine W Striley; Linda B Cottler
Journal:  Curr Opin Psychiatry       Date:  2017-07       Impact factor: 4.741

4.  Influence of opioid prescribing standards on health outcomes among patients with long-term opioid use: a longitudinal cohort study.

Authors:  Richard L Morrow; Ken Bassett; James M Wright; Greg Carney; Colin R Dormuth
Journal:  CMAJ Open       Date:  2020-12-18

5.  Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs.

Authors:  Alexis Crabtree; Caren Rose; Mei Chong; Kate Smolina
Journal:  Can Fam Physician       Date:  2019-05       Impact factor: 3.275

6.  Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.

Authors:  Tara Gomes; Wayne Khuu; Diana Martins; Mina Tadrous; Muhammad M Mamdani; J Michael Paterson; David N Juurlink
Journal:  BMJ       Date:  2018-08-29

7.  Reducing prescribing of benzodiazepines in older adults: a comparison of four physician-focused interventions by a medical regulatory authority.

Authors:  Nigel Ashworth; Nicole Kain; Delaney Wiebe; Nancy Hernandez-Ceron; Ed Jess; Karen Mazurek
Journal:  BMC Fam Pract       Date:  2021-04-08       Impact factor: 2.497

8.  Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid.

Authors:  John C Messinger; Aaron S Kesselheim; Seanna M Vine; Michael A Fischer; Rachel E Barenie
Journal:  Subst Abuse       Date:  2022-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.